Back

Anti-obesity medications in the acute setting: when should we start, stop, or continue?

31 August 2024 (16:55 - 17:15)
Organised by: Logo
Congress Presentation Part of: Dealing with obesity in the cardiac care unit: practical solutions Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Sergio Leonardi

University of Pavia, Pavia (Italy)

2 More presentations in this session

Presentation thumbnail
Impact of obesity on acute cardiovascular outcomes
Professor C. Magnussen (Hamburg, DE)
Slides Video
Presentation thumbnail
Optimising medical therapy and interventions for patients with obesity in the cardiac care unit
Doctor A. Sambola (Barcelona, ES)
Slides Video

Access the full session

Session thumbnail
Dealing with obesity in the cardiac care unit: practical solutions
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 16:55 CET
You may be interested in
thumbnail
Congress Session
A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future
thumbnail
Congress Presentation
Precision pathways to glucose management in patients with diabetes and cardiovascular disease: the out-patient setting
thumbnail
Congress Session
What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources